Literature DB >> 14991948

Effects of low molecular weight heparin on platelet surface P-selectin expression and serum interleukin-8 production in rats with trinitrobenzene sulphonic acid-induced colitis.

Bing Xia1, Hong Han, Ke-Jian Zhang, Jin Li, Guang-Song Guo, Ling-Ling Gong, Xian-Chang Zeng, Jun-Yan Liu.   

Abstract

AIM: To observe the effects of low molecular weight heparin (LMWH) on platelet surface P-selectin expression and serum interleukin-8 production in rats with trinitrobenzene sulphonic acid (TNBS) induced colitis.
METHODS: Colitis was induced in female Sprague-Dawley rats by colonic administration of 2, 4, 6-TNBS. LMWH, a dalteparin (150 U/kg, 300 U/kg), was subcutaneously administrated one hour before induction of colitis and went on once a day for 6 days. Then a half dose was given for the next 7 days. Control animals received the same volume of normal saline once a day for 14 days after treated by TNBS. Animals were sacrificed at 24 h, days 7 and 14 after induction of colitis. The colon was excised for the evaluation of macroscopic and histological findings and TNF-alpha immunohistochemical assay. Platelet surface P-selectin expression was determined by radioimmunoassay and serum IL-8 production was assayed by ELISA method.
RESULTS: LMWH treatment in a dose of 300 U/kg for 14 days significantly improved colonic inflammation by histological examination. Serum IL-8 production in the 300 U/kg treatment group was more significantly decreased at day 14 than that at 24 h (P<0.05). However, platelet surface P-selectin expression and TNF-alpha staining in colonic tissue were not significantly different among the three groups.
CONCLUSION: LMWH has an anti-inflammatory effect on TNBS induced colitis in rats. The effect is possibly related to inhibition of proinflammatory cytokine IL-8, but not involved platelet surface P-selectin expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14991948      PMCID: PMC4716919          DOI: 10.3748/wjg.v10.i5.729

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.

Authors:  C Folwaczny; B Wiebecke; K Loeschke
Journal:  Am J Gastroenterol       Date:  1999-06       Impact factor: 10.864

2.  Misoprostol provides a colonic mucosal protective effect during acetic acid-induced colitis in rats.

Authors:  R N Fedorak; L R Empey; C MacArthur; L D Jewell
Journal:  Gastroenterology       Date:  1990-03       Impact factor: 22.682

3.  Cerebral involvement with disseminated intravascular coagulation in intestinal disease.

Authors:  F P Ryan; W R Timperley; F E Preston; C D Holdsworth
Journal:  J Clin Pathol       Date:  1977-06       Impact factor: 3.411

4.  Low-dose low-molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis: an open trial.

Authors:  I Dotan; A Hallak; N Arber; M Santo; A Alexandrowitz; Y Knaani; R Hershkoviz; E Brazowski; Z Halpern
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

5.  Acute myocardial infarction in a young woman with severe ulcerative colitis.

Authors:  Bülent Mutlu; Cem M H Ermeydan; Feruze Enç; Hakan Fotbolcu; Onur Demirkol; Fatih Bayrak; Yelda Basaran
Journal:  Int J Cardiol       Date:  2002-05       Impact factor: 4.164

6.  Heparin disaccharides inhibit tumor necrosis factor-alpha production by macrophages and arrest immune inflammation in rodents.

Authors:  L Cahalon; O Lider; H Schor; A Avron; D Gilat; R Hershkoviz; R Margalit; A Eshel; O Shoseyev; I R Cohen
Journal:  Int Immunol       Date:  1997-10       Impact factor: 4.823

Review 7.  Platelets and inflammation: role of platelet-derived growth factor, adhesion molecules and histamine.

Authors:  P F Mannaioni; M G Di Bello; E Masini
Journal:  Inflamm Res       Date:  1997-01       Impact factor: 4.575

8.  Spontaneous deep vein thrombosis in childhood and adolescence.

Authors:  L T Nguyen; J M Laberge; F M Guttman; D Albert
Journal:  J Pediatr Surg       Date:  1986-07       Impact factor: 2.545

9.  Platelets circulate in an activated state in inflammatory bowel disease.

Authors:  C E Collins; M R Cahill; A C Newland; D S Rampton
Journal:  Gastroenterology       Date:  1994-04       Impact factor: 22.682

10.  Treatment of corticosteroid-resistant ulcerative colitis with heparin--a report of 16 cases.

Authors:  R C Evans; V S Wong; A I Morris; J M Rhodes
Journal:  Aliment Pharmacol Ther       Date:  1997-12       Impact factor: 8.171

View more
  2 in total

1.  Effects of dermatan sulfate derivatives on platelet surface P-selectin expression and protein C activity in blood of inflammatory bowel disease patients.

Authors:  Sheng-Li Ji; Hai-Yan Du; Yan-Qing Chi; Hui-Fei Cui; Ji-Chao Cao; Mei-Yu Geng; Hua-Shi Guan
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

2.  Efficacy of intracolonic administration of low-molecular-weight heparin CB-01-05, compared to other low-molecular-weight heparins and unfractionated heparin, in experimentally induced colitis in rat.

Authors:  Giuseppe Celasco; Luigi Moro; Roberta Bozzella; Katia Mangano; Cinzia Quattrocchi; Caterina Aiello; Marco Donia; Paolo Fagone; Roberto Di Marco
Journal:  Dig Dis Sci       Date:  2008-05-09       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.